Several Laboratory Variables Indicate Severity and Prognosis of COVID-19

Overview

Journal J Int Med Res

Publisher Sage Publications

Specialty General Medicine

Date 2024 Jan 9

PMID 38194472

Authors

Lingxiang Sheng

Mahong Hu

Conghua Ji

Xiujuan Xu

Affiliations

Soon will be listed here.

Abstract

Objective: While several laboratory variables have been used to assess COVID-19 disease, to our knowledge, no attempt has previously been made to compare differences across different patient groups. We attempted to evaluate the relationship between laboratory variables and severity of the disease as well as on prognosis.

Method: We searched BioLINCC database and identified three studies which had separately included outpatients, inpatients, and ICU patients. For this re-analysis, we extracted data on general demography, laboratory variables and outcome.

Result: In total, 2454 participants (496 outpatients [Study 1], 478 inpatients [Study 2], and 1480 ICU patients [Study 3]) were included in the analysis. We found three laboratory variables (i.e., creatinine, aspartate transferase, and albumin) were not only prognostic factors for outcome of inpatients with COVID-19, but also reflected disease severity as they were significantly different between inpatients and ICU patients. These three laboratory variables are an indication of kidney function, liver function, and nutritional status.

Conclusion: For patients with COVID-19, in addition to monitoring infectious disease indicators, we need to pay attention to liver function, renal function, and take timely measures to correct them to improve prognosis.

References

Wang C, Peng C, Ning L, Qiu X, Wu K, Yang N . Development and Validation of a Nomogram to Assist Monitoring Nosocomial SARS-CoV-2 Infection of Hospitalized Patients. J Inflamm Res. 2022; 15:1471-1481. PMC: 8896769. DOI: 10.2147/JIR.S351509. View

Wu H, Dai R, Wu X, Li Q, Lu H, Yang J . Efficacy and Safety of Chinese Medicine for COVID-19: A Systematic Review and Meta-Analysis. Am J Chin Med. 2022; 50(2):333-349. DOI: 10.1142/S0192415X22500136. View

Self W, Semler M, Leither L, Casey J, Angus D, Brower R . Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial. JAMA. 2020; 324(21):2165-2176. PMC: 7653542. DOI: 10.1001/jama.2020.22240. View

Peltan I, Caldwell E, Admon A, Attia E, Gundel S, Mathews K . Characteristics and Outcomes of US Patients Hospitalized With COVID-19. Am J Crit Care. 2021; 31(2):146-157. PMC: 8891038. DOI: 10.4037/ajcc2022549. View

Mi J, Zhong W, Huang C, Zhang W, Tan L, Ding L . Gender, age and comorbidities as the main prognostic factors in patients with COVID-19 pneumonia. Am J Transl Res. 2020; 12(10):6537-6548. PMC: 7653634. View

Fadda W, Al-Batanony M, Aboukhalil R, Khader H, Al Rugaie O . Comparison between clinical characteristics and laboratory findings among patients with complicated and noncomplicated SARS-CoV-2 infection: A single-center experience from Shebin Al-Kom, Egypt. Immun Inflamm Dis. 2022; 10(8):e671. PMC: 9274799. DOI: 10.1002/iid3.671. View

Ouyang L, Gong Y, Zhu Y, Gong J . Association of acute kidney injury with the severity and mortality of SARS-CoV-2 infection: A meta-analysis. Am J Emerg Med. 2020; 43:149-157. PMC: 7467076. DOI: 10.1016/j.ajem.2020.08.089. View

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007; 147(8):573-7. DOI: 10.7326/0003-4819-147-8-200710160-00010. View

Tardif J, Bouabdallaoui N, LAllier P, Gaudet D, Shah B, Pillinger M . Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial. Lancet Respir Med. 2021; 9(8):924-932. PMC: 8159193. DOI: 10.1016/S2213-2600(21)00222-8. View

10.

Wu H, Dai R, He P, Liang J, Li Q, Yang J . Characteristics analysis for clinical study design relating to COVID-19 based on the database of ClinicalTrials.gov. Int J Infect Dis. 2022; 116:210-215. PMC: 8743275. DOI: 10.1016/j.ijid.2022.01.015. View

11.

Liu H, Shang X, Chen S, Li T, Zhang J . Cautions on the laboratory indicators of COVID-19 patients on and during admission. J Clin Lab Anal. 2021; 35(5):e23767. PMC: 8128304. DOI: 10.1002/jcla.23767. View

12.

Dai W, Ke P, Li Z, Zhuang Q, Huang W, Wang Y . Establishing Classifiers With Clinical Laboratory Indicators to Distinguish COVID-19 From Community-Acquired Pneumonia: Retrospective Cohort Study. J Med Internet Res. 2021; 23(2):e23390. PMC: 7901596. DOI: 10.2196/23390. View

13.

Chen Z, Xu W, Ma W, Shi X, Li S, Hao M . Clinical laboratory evaluation of COVID-19. Clin Chim Acta. 2021; 519:172-182. PMC: 8086377. DOI: 10.1016/j.cca.2021.04.022. View

14.

Li X, Rong Y, Zhang P, Wang J, Qie L, Rong L . Differences in Clinical Features and Laboratory Results between Adults and Children with SARS-CoV-2 Infection. Biomed Res Int. 2020; 2020:6342598. PMC: 7712632. DOI: 10.1155/2020/6342598. View

15.

Cao B, Jing X, Liu Y, Wen R, Wang C . Comparison of laboratory parameters in mild severe cases and died survived patients with COVID-19: systematic review and meta-analysis. J Thorac Dis. 2022; 14(5):1478-1487. PMC: 9186220. DOI: 10.21037/jtd-22-345. View

16.

Wu X, Liu L, Jiao J, Yang L, Zhu B, Li X . Characterisation of clinical, laboratory and imaging factors related to mild vs. severe covid-19 infection: a systematic review and meta-analysis. Ann Med. 2020; 52(7):334-344. PMC: 7877997. DOI: 10.1080/07853890.2020.1802061. View

17.

Liu C, Wang Z, Wu W, Xiang C, Wu L, Li J . Laboratory Testing Implications of Risk-Stratification and Management of COVID-19 Patients. Front Med (Lausanne). 2021; 8:699706. PMC: 8414546. DOI: 10.3389/fmed.2021.699706. View

18.

Ciaccio M, Agnello L . Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19). Diagnosis (Berl). 2020; 7(4):365-372. DOI: 10.1515/dx-2020-0057. View

19.

Giffen C, Wagner E, Adams J, Hitchcock D, Welniak L, Brennan S . Providing researchers with online access to NHLBI biospecimen collections: The results of the first six years of the NHLBI BioLINCC program. PLoS One. 2017; 12(6):e0178141. PMC: 5470669. DOI: 10.1371/journal.pone.0178141. View

20.

Giannos P, Kechagias K, Katsikas Triantafyllidis K, Falagas M . Spotlight on Early COVID-19 Research Productivity: A 1-Year Bibliometric Analysis. Front Public Health. 2022; 10:811885. PMC: 9197383. DOI: 10.3389/fpubh.2022.811885. View